TARIFF CLASSIFICATION | 2026-09-12

Section 232 Pharmaceutical Tariffs: The September 29, 2026 Annex III Effective Date, the 100 Percent Duty on Patented Drugs, and How California Importers Can Reduce Exposure Through Onshoring Agreements

With the Annex III phase of the Section 232 pharmaceutical tariffs scheduled to take effect at 12:01 a.m. on September 29, 2026, California life sciences companies, drug importers, hospitals, and distributors face a 100 percent duty on certain patented pharmaceuticals and their active ingredients unless they qualify for the onshoring and pricing exceptions that the Proclamation makes available.

By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published

The Section 232 pharmaceutical tariffs represent one of the most consequential trade measures of 2026 for California life sciences companies, and a critical compliance date is now imminent.

Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.

Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301